You are here

P&T August 2011

Features

Patients with prostatic enlargement who had taken an alpha blocker and were then given a 5-alpha reductase inhibitor earlier rather than later had a reduced risk of clinical progression, acute urinary retention, and prostate-related surgery, as well as lower medical costs.


Continuing Education Credit
Emerging Therapies for Rhythm Control and Stroke Prevention